|
|
|
Insider
Information: |
Crystal Roger |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
19,623 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$165,814 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
19,623 |
|
|
Total
Value |
$165,814 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
6
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
Percentage
Gain/Loss : |
-45.2%
|
-40.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Opiant Pharmaceuticals Inc |
OPNT |
Chief Executive Office... |
2023-03-02 |
0 |
|
0 |
Premium* |
|
Mind Medicine |
MNMD |
Director |
2023-06-21 |
19,623 |
2022-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2023-03-02 |
4 |
D |
$20.00 |
$1,640,120 |
D/D |
(82,006) |
0 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2023-03-02 |
4 |
D |
$20.00 |
$102,000 |
D/D |
(5,100) |
0 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive OfficerOfficer |
|
2014-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2021-09-16 |
4 |
B |
$23.44 |
$2,344 |
D/D |
100 |
5,100 |
3.15 |
% |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
6,667 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2017-01-17 |
4 |
B |
$6.99 |
$24,290 |
D/D |
3,475 |
8,475 |
3.15 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2018-10-09 |
4 |
AS |
$17.04 |
$118,275 |
D/D |
(6,941) |
8,475 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-01-08 |
4 |
AS |
$13.27 |
$151,371 |
D/D |
(11,407) |
8,475 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-08 |
4 |
AS |
$12.10 |
$154,541 |
D/D |
(12,772) |
8,475 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-02 |
4 |
OE |
$7.25 |
$5,960 |
D/D |
822 |
9,297 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-03 |
4 |
AS |
$12.24 |
$46,402 |
D/D |
(3,791) |
10,055 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-01-04 |
4 |
AS |
$13.54 |
$160,232 |
D/D |
(11,834) |
13,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-02 |
4 |
AS |
$12.48 |
$7,488 |
D/D |
(600) |
13,846 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-03 |
4 |
OE |
$7.25 |
$37,330 |
D/D |
5,149 |
14,446 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2018-10-08 |
4 |
AS |
$17.33 |
$53,012 |
D/D |
(3,059) |
15,416 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-04 |
4 |
AS |
$11.93 |
$200,853 |
D/D |
(16,836) |
15,776 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2018-10-05 |
4 |
AS |
$18.14 |
$15,365 |
D/D |
(847) |
18,475 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2018-10-04 |
4 |
AS |
$18.43 |
$73,831 |
D/D |
(4,006) |
19,322 |
0 |
- |
|
MNMD |
Mind Medicine |
Director |
|
2023-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,671 |
19,623 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-01-07 |
4 |
AS |
$13.28 |
$355,360 |
D/D |
(26,759) |
19,882 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-04-05 |
4 |
AS |
$11.98 |
$191,692 |
D/D |
(16,001) |
21,247 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2020-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
13,650 |
22,125 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2018-10-03 |
4 |
AS |
$19.23 |
$82,689 |
D/D |
(4,300) |
23,328 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2019-01-04 |
4 |
OE |
$7.25 |
$118,603 |
D/D |
16,359 |
24,834 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Executive Officer |
|
2018-10-02 |
4 |
AS |
$17.51 |
$177,621 |
D/D |
(10,144) |
27,628 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|